[go: up one dir, main page]

PL320084A1 - Nucleic acids of amino acid type - Google Patents

Nucleic acids of amino acid type

Info

Publication number
PL320084A1
PL320084A1 PL95320084A PL32008495A PL320084A1 PL 320084 A1 PL320084 A1 PL 320084A1 PL 95320084 A PL95320084 A PL 95320084A PL 32008495 A PL32008495 A PL 32008495A PL 320084 A1 PL320084 A1 PL 320084A1
Authority
PL
Poland
Prior art keywords
amino acid
nucleic acids
acid type
type
nucleic
Prior art date
Application number
PL95320084A
Other versions
PL185852B1 (en
Inventor
Kandasamy Ramasamy
Guangyi Wang
Wilfried Seifert
Original Assignee
Icnpharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icnpharmaceuticals filed Critical Icnpharmaceuticals
Publication of PL320084A1 publication Critical patent/PL320084A1/en
Publication of PL185852B1 publication Critical patent/PL185852B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL95320084A 1994-11-02 1995-11-02 Nucleic acids of amino acid type PL185852B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33389594A 1994-11-02 1994-11-02
PCT/US1995/014599 WO1996014330A1 (en) 1994-11-02 1995-11-02 Amino acid nucleic acids

Publications (2)

Publication Number Publication Date
PL320084A1 true PL320084A1 (en) 1997-09-15
PL185852B1 PL185852B1 (en) 2003-08-29

Family

ID=23304698

Family Applications (1)

Application Number Title Priority Date Filing Date
PL95320084A PL185852B1 (en) 1994-11-02 1995-11-02 Nucleic acids of amino acid type

Country Status (13)

Country Link
EP (1) EP0789707A4 (en)
JP (1) JPH10508312A (en)
KR (1) KR100393336B1 (en)
CN (1) CN1171112A (en)
AU (1) AU693622B2 (en)
CA (1) CA2202274A1 (en)
HU (1) HU218086B (en)
MX (1) MX9703188A (en)
PL (1) PL185852B1 (en)
RU (1) RU2154638C2 (en)
SI (1) SI9520112A (en)
UA (1) UA48150C2 (en)
WO (1) WO1996014330A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840879A (en) * 1996-12-06 1998-11-24 Wang; Edge R. Reagents and solid supports for improved synthesis and labeling of polynucleotides
EP2302391A1 (en) * 2001-04-10 2011-03-30 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic and diagnostic uses of antibody specificity profiles in rheumatoid arthritis
BR122019021332A8 (en) * 2007-11-15 2022-12-06 Avi Biopharma Inc MORPHOLIN OLIGOMER SYNTHESIS PROCESS
JP5199519B2 (en) * 2010-11-30 2013-05-15 独立行政法人科学技術振興機構 Nucleoside analogs or salts thereof, oligonucleotide analogs, gene expression inhibitors, and nucleic acid probes for gene detection
RU2460721C1 (en) * 2011-02-25 2012-09-10 Учреждение Российской академии наук Институт химической биологии и фундаментальной медицины Сибирского отделения РАН (ИХБФМ СО РАН) Method of producing amidophosphite monomer of achiral non-nucleotide insert for modifying oligonucleotides
DE102014007158A1 (en) * 2014-05-16 2015-11-19 Ugichem Gmbh New peptide-nucleic acid monomers and oligomers
MX2019014415A (en) * 2017-06-16 2020-02-05 Eisai R&D Man Co Ltd Modified nucleic acid monomer compound and oligonucleic acid analog.
CN113956183B (en) * 2021-10-28 2023-06-20 成都市科隆化学品有限公司 Boc-Ser (Bzl) -OH and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3022967B2 (en) * 1985-03-15 2000-03-21 アンチバイラルズ インコーポレイテッド Stereoregular polynucleotide binding polymer
DK51092D0 (en) * 1991-05-24 1992-04-15 Ole Buchardt OLIGONUCLEOTIDE ANALOGUE DESCRIBED BY PEN, MONOMERIC SYNTHONES AND PROCEDURES FOR PREPARING THEREOF, AND APPLICATIONS THEREOF

Also Published As

Publication number Publication date
SI9520112A (en) 1998-08-31
EP0789707A1 (en) 1997-08-20
WO1996014330A1 (en) 1996-05-17
PL185852B1 (en) 2003-08-29
RU2154638C2 (en) 2000-08-20
CA2202274A1 (en) 1996-05-17
MX9703188A (en) 1997-12-31
AU4234196A (en) 1996-05-31
KR100393336B1 (en) 2003-12-24
AU693622B2 (en) 1998-07-02
EP0789707A4 (en) 1999-02-24
CN1171112A (en) 1998-01-21
JPH10508312A (en) 1998-08-18
KR970707144A (en) 1997-12-01
HUT77435A (en) 1998-04-28
HU218086B (en) 2000-05-28
UA48150C2 (en) 2002-08-15

Similar Documents

Publication Publication Date Title
GB9620769D0 (en) Nucleic acid sequencing
GB9212164D0 (en) Preparation of nucleic acids
HUP0000810A3 (en) Proteins with enhanced levels of essential amino acids
IL114910A0 (en) Snthetic excitatory amino acids
ZA987257B (en) Amplification of nucleic acids
GB2316411B (en) Nucleic Acid Sequencing Gels
ZA9810650B (en) Process to stabilize proteins
ZA9810669B (en) Process for the preparation of 8-methoxy-quinolone-carbyxylic acids
IL130886A0 (en) Nucleic acid sequencing
PL320084A1 (en) Nucleic acids of amino acid type
GB9517914D0 (en) Identification of bases in nucleic acid sequences
GB9717932D0 (en) Estimation of nucleic acid
IL136988A0 (en) Novel nucleic acid and polypeptide
PL317853A1 (en) Derivatives of amino acids
IL120715A0 (en) Process for the preparation of trifluoroethoxy-arenecarboxylic acids
GB9420010D0 (en) Nucleic acids
IL111857A0 (en) Detection of nucleic acid sequences
GB9725839D0 (en) Isolation of nucleic acids
GB9408064D0 (en) Nucleic acids
HUT75695A (en) Recovery of an amino acid
GB2316073B (en) Alkylation of amino acids
GB9512092D0 (en) Proteins and nucleic acids
IL108591A0 (en) Amino acid sequence determination
IL120283A0 (en) Nucleic acid sequences and proteins
AU5539096A (en) Nucleic acid sequencing

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20051102